Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00268047 · ClinicalTrials.gov registry record
Pulmonary Resistance in Fontan Who Have Undergone Heart Transplantation
A clinical trial, sponsored by Children's Healthcare of Atlanta.
- Terminated
- Registry status
- 50
- Enrollment target
NCT00268047: Clinical Trial study, sponsored by Children's Healthcare of Atlanta.
NCT00268047 is a clinical trial that was terminated before completion, run by Children's Healthcare of Atlanta. The registered enrollment target is 50 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00268047 was terminated before completion, sponsored by Children's Healthcare of Atlanta.
- TERMINATED
- Registry status
- 50 participants
- Enrollment target
Study Summary
Clinical evidence reveals that some patients who undergo cardiac transplantation exhibit problems with pulmonary vascular resistance as well. In some studies, an increase in pulmonary vascular resistance has been used as an indicator for increased 3-day and 3-month mortality after heart transplantation2. In this study, the investigators would like to look at pulmonary vascular resistance in patients with a surgical history of the Fontan procedure followed by heart transplantation.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
Why NCT00268047 stopped before completion
NCT00268047 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 50 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT00268047 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00268047 about?
NCT00268047 is a clinical study titled "Pulmonary Resistance in Fontan Who Have Undergone Heart Transplantation". Clinical evidence reveals that some patients who undergo cardiac transplantation exhibit problems with pulmonary vascular resistance as well. In some studies, an increase in pulmonary vascular resistance has been used as an indicator for increased 3-day and 3-month mortality after heart transplantat...
What is the current status of trial NCT00268047?
This trial is currently terminated. The enrollment target is 50 participants.
Who is sponsoring clinical trial NCT00268047?
This trial is sponsored by Children's Healthcare of Atlanta, which has 80 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00200889 · 50 participants · Early Phase 1
Mapping Auricular Vagus Nerve Circuitry
- NCT00409435 · 50 participants · Phase 2
A Study of Pyridostigmine in Postural Tachycardia Syndrome
- NCT01202305 · 50 participants
The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies
- NCT01225913 · 50 participants · Phase 4
Mechanism(s) of Airflow Limitation During Exacerbation of Asthma